[go: up one dir, main page]

IS4224A - Lyfjablanda á formi dropalausnar sem inniheldur skammvirkt kalsíummótlyf af tvíhýdrópýridíngerð semvinna gegn háþrýstingi - Google Patents

Lyfjablanda á formi dropalausnar sem inniheldur skammvirkt kalsíummótlyf af tvíhýdrópýridíngerð semvinna gegn háþrýstingi

Info

Publication number
IS4224A
IS4224A IS4224A IS4224A IS4224A IS 4224 A IS4224 A IS 4224A IS 4224 A IS4224 A IS 4224A IS 4224 A IS4224 A IS 4224A IS 4224 A IS4224 A IS 4224A
Authority
IS
Iceland
Prior art keywords
short
antidote
dihydropyridine
antidepressant
pharmaceutical formulation
Prior art date
Application number
IS4224A
Other languages
English (en)
Other versions
IS2036B (is
Inventor
Hjalmar Andersson Kjell
Christina Byröd Eva
Hansson Anna-Carin
Nordlander Margareta
Christer Westerlund Rolf
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS4224A publication Critical patent/IS4224A/is
Publication of IS2036B publication Critical patent/IS2036B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IS4224A 1993-11-12 1994-10-21 Lyfjablanda á formi dropalausnar sem inniheldur skammvirkt kalsíummótlyf af tvíhýdrópýridíngerð semvinna gegn háþrýstingi IS2036B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303744A SE9303744D0 (sv) 1993-11-12 1993-11-12 Pharmaceutical emulsion

Publications (2)

Publication Number Publication Date
IS4224A true IS4224A (is) 1995-05-13
IS2036B IS2036B (is) 2005-08-15

Family

ID=20391731

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4224A IS2036B (is) 1993-11-12 1994-10-21 Lyfjablanda á formi dropalausnar sem inniheldur skammvirkt kalsíummótlyf af tvíhýdrópýridíngerð semvinna gegn háþrýstingi

Country Status (31)

Country Link
US (1) US5739152A (is)
EP (1) EP0727997B1 (is)
JP (1) JP3759951B2 (is)
KR (1) KR100345627B1 (is)
CN (1) CN1072934C (is)
AT (1) ATE213158T1 (is)
AU (1) AU678650B2 (is)
CA (1) CA2176360C (is)
CZ (1) CZ290772B6 (is)
DE (1) DE69429871T2 (is)
DK (1) DK0727997T3 (is)
EE (1) EE03223B1 (is)
EG (1) EG20764A (is)
ES (1) ES2172572T3 (is)
FI (1) FI116999B (is)
HK (1) HK1013261A1 (is)
HU (1) HU223142B1 (is)
IL (1) IL111345A (is)
IS (1) IS2036B (is)
MY (1) MY121201A (is)
NO (1) NO314877B1 (is)
NZ (1) NZ276197A (is)
PL (1) PL181462B1 (is)
PT (1) PT727997E (is)
RU (1) RU2144358C1 (is)
SA (1) SA94150314B1 (is)
SE (1) SE9303744D0 (is)
SK (1) SK283271B6 (is)
UA (1) UA40633C2 (is)
WO (1) WO1995013066A1 (is)
ZA (1) ZA948180B (is)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
EP1079808B1 (en) * 1998-05-29 2004-02-11 Skyepharma Canada Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
SE9804002D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New manufacturing process
DE10036871A1 (de) 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
EP1401396A4 (en) 2001-06-15 2009-08-05 Cornerstone Pharmaceuticals PHARMACEUTICAL AND DIAGNOSTIC COMPOSITIONS WITH NANOPARTICLES FOR THE TREATMENT OF TARGET TISSUE AND CELLS
BRPI0409133B8 (pt) 2003-04-08 2021-05-25 Progenics Pharm Inc preparações farmacêuticas estavéis compreendendo metilnaltrexona
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
EP2139890B1 (en) * 2007-03-29 2014-06-25 Wyeth LLC Peripheral opioid receptor antagonists and uses thereof
BRPI0809579B8 (pt) 2007-03-29 2021-05-25 Progenics Pharm Inc formas cristalinas e seus usos
CA2682125C (en) 2007-03-29 2015-06-16 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
KR101581480B1 (ko) 2008-02-06 2015-12-30 프로제닉스 파머슈티컬스, 인코포레이티드 (ｒ),(ｒ)-2,2'-비스-메틸날트렉손의 제조법 및 용도
JP2011529879A (ja) * 2008-08-01 2011-12-15 ザ メディシンズ カンパニー 医薬組成物およびこれを安定化させる方法
EA021336B1 (ru) * 2008-08-01 2015-05-29 Дзе Медсинз Компани Фармацевтические композиции и способы их получения при низкой концентрации примесей
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
WO2010107081A1 (ja) * 2009-03-19 2010-09-23 第一三共株式会社 包装により安定保存された固形製剤
CN101780036B (zh) * 2010-03-30 2011-11-16 武汉武药科技有限公司 丁酸氯维地平脂微球注射液及其制备方法
US8658676B2 (en) * 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
DK2627173T4 (en) * 2010-10-12 2018-10-22 Chiesi Farm Spa CLEVIDIPINE EMULSUM FORMULATIONS CONTAINING ANTIMICROBIANTS
CN102531998A (zh) * 2010-12-09 2012-07-04 天津药物研究院 α型多晶型丁酸氯维地平结晶、其制备方法、用途和药物组合物
CN102525918A (zh) * 2010-12-30 2012-07-04 天津药物研究院 一种丁酸氯维地平的脂肪乳注射液及其制备工艺
US20120213855A1 (en) * 2011-02-17 2012-08-23 Cima Labs Inc. Dosage forms for weakly ionizable compounds
AU2012236332A1 (en) 2011-04-01 2013-10-31 Chiesi Farmaceutici S.P.A. Short -acting dihydropyridines (clevidipine) for use in reducing stroke damage
CN110075310A (zh) 2011-12-20 2019-08-02 维奥姆治疗有限公司 用于治疗真菌感染的局部油组合物
TR201807636T4 (tr) 2012-10-26 2018-06-21 Chiesi Farm Spa Kalp yetmezliğinde kan basıncının kontrol edilmesi ve dispnenin azaltılması için yöntemler.
CN103110580B (zh) * 2013-02-20 2014-09-17 北京德立福瑞医药科技有限公司 丁酸氯维地平注射剂
KR101862448B1 (ko) * 2013-04-12 2018-05-29 바이옴 바이오사이언스 피브이티. 엘티디. 항균제의 조성물과 제제, 그 공정, 및 세균 감염을 치료하는 방법
US11737989B2 (en) 2014-05-19 2023-08-29 Chiesi Farmaceutici S.P.A. Clevidipine nanoparticles and pharmaceutical compositions thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315805A1 (de) * 1983-04-30 1984-11-08 Bayer Ag, 5090 Leverkusen Wirkstoffzubereitungen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE3515335C2 (de) * 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4217842A1 (de) * 1992-05-29 1993-12-02 Dietl Hans Calciumantagonisten enthaltende pharmazeutische Zubereitung zur intravenösen und intrakoronaren Applikation sowie Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
PT727997E (pt) 2002-07-31
FI961999L (fi) 1996-05-10
FI961999A0 (fi) 1996-05-10
CN1136774A (zh) 1996-11-27
CZ290772B6 (cs) 2002-10-16
WO1995013066A1 (en) 1995-05-18
EP0727997B1 (en) 2002-02-13
AU1037195A (en) 1995-05-29
HU9601268D0 (en) 1996-07-29
DE69429871T2 (de) 2002-08-22
FI116999B (fi) 2006-05-15
HU223142B1 (hu) 2004-03-29
KR100345627B1 (ko) 2003-03-15
SK59796A3 (en) 1996-12-04
NO314877B1 (no) 2003-06-10
ES2172572T3 (es) 2002-10-01
CA2176360A1 (en) 1995-05-18
ATE213158T1 (de) 2002-02-15
DE69429871D1 (de) 2002-03-21
DK0727997T3 (da) 2002-04-22
HUT74474A (en) 1996-12-30
UA40633C2 (uk) 2001-08-15
MY121201A (en) 2006-01-28
NO961898D0 (no) 1996-05-10
SE9303744D0 (sv) 1993-11-12
IL111345A0 (en) 1994-12-29
EE03223B1 (et) 1999-10-15
IL111345A (en) 2000-08-31
JP3759951B2 (ja) 2006-03-29
PL314263A1 (en) 1996-09-02
RU2144358C1 (ru) 2000-01-20
US5739152A (en) 1998-04-14
PL181462B1 (pl) 2001-07-31
EG20764A (en) 2000-01-31
HK1013261A1 (en) 1999-08-20
CN1072934C (zh) 2001-10-17
NO961898L (no) 1996-06-25
CA2176360C (en) 2005-08-23
IS2036B (is) 2005-08-15
NZ276197A (en) 1997-04-24
EP0727997A1 (en) 1996-08-28
CZ133896A3 (en) 1996-09-11
JPH09505045A (ja) 1997-05-20
ZA948180B (en) 1995-05-12
AU678650B2 (en) 1997-06-05
SA94150314B1 (ar) 2005-06-14
SK283271B6 (sk) 2003-04-01

Similar Documents

Publication Publication Date Title
IS4224A (is) Lyfjablanda á formi dropalausnar sem inniheldur skammvirkt kalsíummótlyf af tvíhýdrópýridíngerð semvinna gegn háþrýstingi
DK0850046T3 (da) Mikroemulsioner til anvendelse som vhikel til indgift af active forbindelser
FI924553A0 (fi) Tiofensulfonamider anvaendbara som kolanhydrasinhibitorer
DK0778775T3 (da) Parenteral tirilazad-præparat med coopløsningsmiddel
DE69129800D1 (de) Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
ATE195117T1 (de) 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
MA23344A1 (fr) Nouvelles compositions d'emulsions
NO870560L (no) Nytt farmasoeytisk preparat.
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
SE8804628D0 (sv) New compounds
DK0701449T3 (da) Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
KR960703593A (ko) (R)-암로디핀에 의한 평활근 세포 이동의 억제 (Inhibition of Smooth Muscle Cell Migration by (R)-Amlodipine)
SE8904127D0 (sv) New biocyclic amino-substituted compounds
NO955313D0 (no) Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering
DK0689441T3 (da) Farmaceutisk præparat i form af et kit omfattende prostaglandin E1
ITRM940322A0 (it) "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".
DE68905820D1 (de) Pharmazeutische formulierungen.
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
MX9709561A (es) Composiciones de la emulsion de huorocarbobo inverso (privado) para el suministro de medicamento.